AstraZeneca 2Q Revenues: $6.7 billion (-21%) 2Q Earnings: $1.6 billion (-19%) YTD Revenues: $14.0 billion (-16%) YTD Earnings: $3.3 billion (-23%) Comments: U.S. revenues were down 29%, with the loss of exclusivity for Seroquel IR accounting for 80% of the revenue decline. Revenue in the Rest of World (ROW) was down 12% in the quarter. Loss of exclusivity on several key brands accounted for 15% of the revenue decline in the quarter. Nexium sales were $949 million (-13% at CER). Seroquel sal...